Home
Reels
Groepen
Pagina
Kijk verder.....
Groepen Pagina Events Blogs Offers Jobs Courses Movies Merits
Log in Creëer je account
Theme Switcher
Night Mode
Sponsor
Advancements in Niemann-Pick Disease Type C Treatments: A Path Toward Better Outcomes
Zavesca (Miglustat): The Current Approved Therapy for Niemann-Pick Disease Type C Niemann-Pick Disease Type C (NPC) is a rare, progressive, and life-threatening lysosomal storage disorder marked by neurological and visceral complications. At present, Zavesca (miglustat), also sold as Brazaves, is the only approved therapy available for Niemann-Pick Type C treatment. Miglustat works by...
0 Reacties ·0 aandelen ·82 Views ·0 voorbeeld
Please log in to like, share and comment!
Sponsor
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
Sponsor
Sponsor